Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Ketamine for Major Depressive Disorder
Phase 1
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: SHX-001 Active low doseDrug: PlaceboDrug: SHX-001 Active High dose
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- Shenox Pharmaceuticals, LLC
- Target Recruit Count
- 14
- Registration Number
- NCT03721900
- Locations
- 🇺🇸
Clinical Research Site, Dayton, Ohio, United States
News
No news found